4538 — Fuso Pharmaceutical Industries Cashflow Statement
0.000.00%
Last trade - 00:00- ¥18bn
- ¥33bn
- ¥61bn
- 49
- 95
- 31
- 64
Annual cashflow statement for Fuso Pharmaceutical Industries, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2,345 | 1,911 | 2,205 | 1,767 | 3,773 |
| Depreciation | |||||
| Non-Cash Items | -46 | 46 | -59 | 25 | 30 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,479 | -1,019 | -1,779 | -3,427 | -9,463 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 3,230 | 3,497 | 2,853 | 628 | -3,306 |
| Capital Expenditures | -1,210 | -1,487 | -1,574 | -3,588 | -3,098 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 232 | -66 | 201 | 52 | -70 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -978 | -1,553 | -1,373 | -3,536 | -3,168 |
| Financing Cash Flow Items | -1 | -1 | -1 | -2 | -308 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -2,446 | -1,671 | -813 | 14 | 7,618 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -194 | 273 | 667 | -2,894 | 1,144 |